1-9 of 9
Authors: Paul Bird
Save search
Sort by
Journal Article
EDITOR'S CHOICE

Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis

PDF
Joshua Nazareth and others
Open Forum Infectious Diseases, Volume 9, Issue 11, November 2022, ofac509, https://doi.org/10.1093/ofid/ofac509
Published: 01 October 2022
Journal Article

Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis

PDF
Mikkel Østergaard and others
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4305–4313, https://doi.org/10.1093/rheumatology/keac073
Published: 08 February 2022
Journal Article

Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients

PDF
Alvin F Wells and others
Rheumatology, Volume 61, Issue 3, March 2022, Pages 1035–1043, https://doi.org/10.1093/rheumatology/keab449
Published: 08 June 2021
Journal Article

P178 The impact of peripheral articular manifestations on the efficacy of ixekizumab in patients with radiographic axial spondyloarthritis

PDF
Raj Sengupta and others
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab247.173, https://doi.org/10.1093/rheumatology/keab247.173
Published: 26 April 2021
Journal Article

Percutaneous Vertebroplasty for Acute Painful Osteoporotic Vertebral Fractures—Benefits Shown in VAPOUR Trial Masked When Pooled With Other Clinical Trials Get access

PDF
Terrence Diamond and others
Journal of Bone and Mineral Research, Volume 34, Issue 6, 1 June 2019, Pages 1182–1184, https://doi.org/10.1002/jbmr.3725
Published: 28 May 2019
Journal Article

226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population Get access

PDF
Maxime Dougados and others
Rheumatology, Volume 57, Issue suppl_3, April 2018, key075.450, https://doi.org/10.1093/rheumatology/key075.450
Published: 25 April 2018
Journal Article

Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial

PDF
Alvin F Wells and others
Rheumatology, Volume 57, Issue 7, July 2018, Pages 1253–1263, https://doi.org/10.1093/rheumatology/key032
Published: 04 April 2018
Journal Article

194 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104 Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials Get access

PDF
Arthur Kavanaugh and others
Rheumatology, Volume 55, Issue suppl_1, April 2016, Pages i140–i141, https://doi.org/10.1093/rheumatology/kew145.005
Published: 24 April 2016
Journal Article

No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial Get access

PDF
René Panduro Poggenborg and others
Rheumatology, Volume 53, Issue 4, April 2014, Pages 746–756, https://doi.org/10.1093/rheumatology/ket426
Published: 24 December 2013